Hologic Free Cash Flow Per Share vs Capex To Revenue Analysis

HOLX Stock

USD 79.73 0.76 0.96%

Hologic financial indicator trend analysis is much more than just examining Hologic latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hologic is a good investment. Please check the relationship between Hologic Free Cash Flow Per Share and its Capex To Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Free Cash Flow Per Share vs Capex To Revenue

Free Cash Flow Per Share vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hologic Free Cash Flow Per Share account and Capex To Revenue. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Hologic's Free Cash Flow Per Share and Capex To Revenue is -0.54. Overlapping area represents the amount of variation of Free Cash Flow Per Share that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Hologic, assuming nothing else is changed. The correlation between historical values of Hologic's Free Cash Flow Per Share and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Per Share of Hologic are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Free Cash Flow Per Share i.e., Hologic's Free Cash Flow Per Share and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

-0.54

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from Hologic's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hologic current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.At this time, Hologic's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.11 in 2024, whereas Tax Provision is likely to drop slightly above 138.5 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	95.1M	111.1M	122.1M	74.8M
Depreciation And Amortization	430.1M	323.4M	309M	324.5M

Interest Expense Depreciation And Amortization

Hologic fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Total Current Assets	Non Currrent Assets Other	Other Current Assets	Other Current Liab	Accounts Payable	Short Term Debt	Property Plant And Equipment Gross	Short Term Investments	Common Stock	Other Assets
Total Assets		0.69	0.52	0.71	0.94	0.28	0.08	0.54	0.75	0.53	0.51	0.73	0.63	0.71	0.62	0.69	0.63	0.41	0.49	0.71	0.37	0.08	0.6	0.14	0.8	0.36
Short Long Term Debt Total	0.69		0.31	0.0	0.62	0.85	-0.61	-0.14	0.97	-0.16	0.17	0.83	0.97	0.03	0.88	1.0	-0.07	-0.13	0.03	0.16	-0.28	0.31	-0.13	-0.47	0.66	-0.01
Total Current Liabilities	0.52	0.31		0.43	0.7	0.12	-0.01	0.23	0.38	0.22	0.66	0.64	0.1	0.44	0.45	0.32	0.37	0.3	0.27	0.65	0.22	0.76	0.33	-0.05	0.67	0.29
Total Stockholder Equity	0.71	0.0	0.43		0.7	-0.46	0.73	0.92	0.12	0.92	0.58	0.25	-0.06	0.97	0.02	0.0	0.97	0.68	0.69	0.85	0.71	-0.19	0.97	0.57	0.53	0.53
Property Plant And Equipment Net	0.94	0.62	0.7	0.7		0.25	0.05	0.48	0.67	0.48	0.71	0.8	0.5	0.74	0.66	0.61	0.64	0.48	0.49	0.82	0.42	0.21	0.61	0.13	0.88	0.44
Net Debt	0.28	0.85	0.12	-0.46	0.25		-0.9	-0.63	0.78	-0.64	-0.06	0.6	0.85	-0.42	0.76	0.85	-0.55	-0.39	-0.26	-0.21	-0.49	0.39	-0.56	-0.61	0.3	-0.23
Retained Earnings	0.08	-0.61	-0.01	0.73	0.05	-0.9		0.81	-0.51	0.82	0.24	-0.43	-0.62	0.66	-0.63	-0.61	0.77	0.57	0.55	0.47	0.6	-0.43	0.79	0.69	-0.09	0.42
Cash	0.54	-0.14	0.23	0.92	0.48	-0.63	0.81		-0.08	1.0	0.37	0.06	-0.19	0.89	-0.17	-0.16	0.96	0.62	0.53	0.68	0.63	-0.31	0.91	0.56	0.36	0.43
Non Current Assets Total	0.75	0.97	0.38	0.12	0.67	0.78	-0.51	-0.08		-0.09	0.21	0.85	0.94	0.11	0.89	0.98	0.01	-0.09	0.13	0.22	-0.2	0.33	-0.02	-0.41	0.73	0.01
Cash And Short Term Investments	0.53	-0.16	0.22	0.92	0.48	-0.64	0.82	1.0	-0.09		0.36	0.04	-0.2	0.9	-0.18	-0.17	0.96	0.64	0.52	0.68	0.67	-0.32	0.92	0.61	0.35	0.42
Net Receivables	0.51	0.17	0.66	0.58	0.71	-0.06	0.24	0.37	0.21	0.36		0.5	0.02	0.62	0.25	0.16	0.6	0.67	0.58	0.85	0.3	0.14	0.55	0.12	0.64	0.82
Common Stock Shares Outstanding	0.73	0.83	0.64	0.25	0.8	0.6	-0.43	0.06	0.85	0.04	0.5		0.72	0.29	0.91	0.84	0.18	0.05	0.14	0.44	-0.08	0.44	0.11	-0.39	0.92	0.15
Non Current Liabilities Total	0.63	0.97	0.1	-0.06	0.5	0.85	-0.62	-0.19	0.94	-0.2	0.02	0.72		-0.05	0.82	0.97	-0.14	-0.18	-0.01	0.02	-0.29	0.14	-0.17	-0.44	0.54	-0.08
Inventory	0.71	0.03	0.44	0.97	0.74	-0.42	0.66	0.89	0.11	0.9	0.62	0.29	-0.05		0.09	0.02	0.96	0.69	0.61	0.9	0.74	-0.22	0.93	0.58	0.58	0.53
Other Stockholder Equity	0.62	0.88	0.45	0.02	0.66	0.76	-0.63	-0.17	0.89	-0.18	0.25	0.91	0.82	0.09		0.89	-0.07	-0.07	-0.08	0.23	-0.06	0.39	-0.1	-0.33	0.79	-0.04
Total Liab	0.69	1.0	0.32	0.0	0.61	0.85	-0.61	-0.16	0.98	-0.17	0.16	0.84	0.97	0.02	0.89		-0.08	-0.14	0.04	0.14	-0.28	0.32	-0.12	-0.48	0.67	-0.02
Total Current Assets	0.63	-0.07	0.37	0.97	0.64	-0.55	0.77	0.96	0.01	0.96	0.6	0.18	-0.14	0.96	-0.07	-0.08		0.71	0.67	0.83	0.67	-0.25	0.97	0.56	0.49	0.58
Non Currrent Assets Other	0.41	-0.13	0.3	0.68	0.48	-0.39	0.57	0.62	-0.09	0.64	0.67	0.05	-0.18	0.69	-0.07	-0.14	0.71		0.37	0.78	0.7	-0.23	0.69	0.68	0.31	0.87
Other Current Assets	0.49	0.03	0.27	0.69	0.49	-0.26	0.55	0.53	0.13	0.52	0.58	0.14	-0.01	0.61	-0.08	0.04	0.67	0.37		0.57	0.3	-0.18	0.75	0.25	0.33	0.47
Other Current Liab	0.71	0.16	0.65	0.85	0.82	-0.21	0.47	0.68	0.22	0.68	0.85	0.44	0.02	0.9	0.23	0.14	0.83	0.78	0.57		0.66	0.0	0.79	0.45	0.67	0.71
Accounts Payable	0.37	-0.28	0.22	0.71	0.42	-0.49	0.6	0.63	-0.2	0.67	0.3	-0.08	-0.29	0.74	-0.06	-0.28	0.67	0.7	0.3	0.66		-0.28	0.75	0.93	0.21	0.34
Short Term Debt	0.08	0.31	0.76	-0.19	0.21	0.39	-0.43	-0.31	0.33	-0.32	0.14	0.44	0.14	-0.22	0.39	0.32	-0.25	-0.23	-0.18	0.0	-0.28		-0.28	-0.44	0.28	-0.18
Property Plant And Equipment Gross	0.6	-0.13	0.33	0.97	0.61	-0.56	0.79	0.91	-0.02	0.92	0.55	0.11	-0.17	0.93	-0.1	-0.12	0.97	0.69	0.75	0.79	0.75	-0.28		0.67	0.42	0.53
Short Term Investments	0.14	-0.47	-0.05	0.57	0.13	-0.61	0.69	0.56	-0.41	0.61	0.12	-0.39	-0.44	0.58	-0.33	-0.48	0.56	0.68	0.25	0.45	0.93	-0.44	0.67		-0.09	0.34
Common Stock	0.8	0.66	0.67	0.53	0.88	0.3	-0.09	0.36	0.73	0.35	0.64	0.92	0.54	0.58	0.79	0.67	0.49	0.31	0.33	0.67	0.21	0.28	0.42	-0.09		0.33
Other Assets	0.36	-0.01	0.29	0.53	0.44	-0.23	0.42	0.43	0.01	0.42	0.82	0.15	-0.08	0.53	-0.04	-0.02	0.58	0.87	0.47	0.71	0.34	-0.18	0.53	0.34	0.33

Click cells to compare fundamentals

Hologic Account Relationship Matchups

Hologic fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	7.2B	8.9B	9.1B	9.1B	9.2B	9.6B
Short Long Term Debt Total	3.1B	3.0B	2.8B	2.8B	2.5B	1.9B
Total Current Liabilities	1.2B	1.3B	937.7M	1.2B	1.0B	1.1B
Total Stockholder Equity	2.7B	4.2B	4.9B	5.0B	5.1B	5.4B
Property Plant And Equipment Net	491.5M	564.7M	481.6M	517M	537.8M	564.7M
Net Debt	2.3B	1.9B	483.9M	95.7M	374.4M	355.7M
Retained Earnings	(1.6B)	298.3M	1.6B	2.1B	1.9B	1.9B
Cash	701M	1.2B	2.3B	2.7B	2.2B	2.3B
Non Current Assets Total	5.0B	5.8B	5.2B	5.0B	5.3B	3.1B
Cash And Short Term Investments	701M	1.2B	2.3B	2.7B	2.3B	2.5B
Net Receivables	1.0B	942.7M	617.6M	625.6M	600.4M	630.4M
Common Stock Shares Outstanding	264.6M	259.7M	253.8M	248.8M	237.6M	170.5M
Liabilities And Stockholders Equity	7.2B	8.9B	9.1B	9.1B	9.2B	9.6B
Non Current Liabilities Total	3.2B	3.4B	3.3B	2.9B	3.0B	2.0B
Inventory	395.1M	501.2M	623.7M	617.6M	679.8M	713.8M
Other Stockholder Equity	4.3B	4.0B	3.5B	3.1B	5.1B	2.6B
Total Liab	4.5B	4.7B	4.2B	4.1B	4.0B	2.5B
Total Current Assets	2.2B	3.2B	3.9B	4.2B	3.8B	4.0B
Non Currrent Assets Other	489.7M	214.3M	188.8M	267.9M	410.8M	431.3M
Other Current Assets	97.3M	554.5M	281.2M	218.8M	209.5M	220.0M
Other Current Liab	549.5M	498.5M	467.9M	490.8M	564.4M	592.6M
Accounts Payable	178.8M	215.9M	197.7M	175.2M	786.8M	826.1M
Short Term Debt	324.9M	343.5M	41.4M	310.5M	37.5M	35.6M
Property Plant And Equipment Gross	572.2M	1.3B	1.3B	1.3B	1.5B	1.6B
Accumulated Other Comprehensive Income	(49.7M)	(59.1M)	(238.2M)	(147.6M)	(132.8M)	(126.2M)
Short Term Investments	6M	100K	31.9M	16.2M	173.4M	182.1M
Other Assets	424.5M	245.7M	210.5M	179M	205.9M	216.1M
Long Term Debt	2.7B	2.7B	2.8B	2.5B	2.9B	2.2B
Treasury Stock	(926M)	(1.6B)	(2.0B)	(2.5B)	(2.3B)	(2.2B)
Intangible Assets	1.3B	1.7B	1.3B	888.6M	1.0B	1.8B
Property Plant Equipment	491.5M	564.7M	481.6M	579.7M	666.7M	337.5M
Current Deferred Revenue	186.1M	198M	186.5M	199.2M	212.9M	132.4M
Good Will	2.7B	3.3B	3.2B	3.3B	3.8B	2.3B
Other Liab	429.3M	662.3M	448.9M	321.5M	369.7M	441.1M
Net Tangible Assets	(1.3B)	(722.2M)	359.1M	847M	974.1M	1.0B
Long Term Debt Total	2.8B	2.7B	2.7B	2.8B	3.2B	3.2B
Capital Surpluse	5.8B	5.9B	6.0B	6.0B	6.9B	6.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Hologic Free Cash Flow Per Share vs Capex To Revenue Analysis

Free Cash Flow Per Share vs Capex To Revenue

Free Cash Flow Per Share vs Capex To Revenue Correlation Analysis

Correlation Coefficient

Free Cash Flow Per Share

Capex To Revenue

Hologic fundamental ratios Correlations

Hologic Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Hologic fundamental ratios Accounts

Also Currently Popular

Additional Tools for Hologic Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 0.98	Non Current Assets Total
Non Current Assets Total	+ 0.97	Short Long Term Debt Total
Non Current Liabilities Total	+ 0.97	Short Long Term Debt Total
Inventory	+ 0.97	Total Stockholder Equity

Retained Earnings	- 0.9	Net Debt
Cash And Short Term Investments	- 0.64	Net Debt
Other Stockholder Equity	- 0.63	Retained Earnings
Cash	- 0.63	Net Debt
Non Current Liabilities Total	- 0.62	Retained Earnings
Total Liab	- 0.61	Retained Earnings